Log In
BCIQ
Print this Print this
 

Augentropfen

  Manage Alerts
Collapse Summary General Information
Company Pharma Stulln GmbH
DescriptionPreservative free eye drop
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation
PartnerChina Medical System Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/01/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today